Literature DB >> 6830367

Bilateral simultaneous lung lavage utilizing membrane oxygenator for pulmonary alveolar proteinosis in an 8-month-old infant.

L F Hiratzka, D M Swan, E F Rose, R C Ahrens.   

Abstract

Pulmonary alveolar proteinosis can result in severe hypoxemia. Treatment of symptomatic patients using unilateral or lobar staged lung lavage often results in improved oxygenation and functional capacity. Lung lavage is technically difficult in infants and small children because of inability to ventilate part of the lung safely and adequately during lavage of other areas. We used extracorporeal membrane oxygenation to facilitate adequate gas exchange during lung lavage for severe respiratory failure in a 3.7 kg, 8-month-old child with pulmonary alveolar proteinosis. Oxygenation was markedly improved immediately following the procedure. Extracorporeal membrane oxygenation permits satisfactory respiratory support in the setting of severe respiratory failure and should be considered an adjunct for treatment of pulmonary alveolar proteinosis when lung lavage cannot be otherwise safely accomplished.

Entities:  

Mesh:

Year:  1983        PMID: 6830367     DOI: 10.1016/s0003-4975(10)61565-2

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Challenges during repeat extracorporeal life support in a patient with pulmonary alveolar proteinosis.

Authors:  Hemanth Lingadevaru; Matthew A Romano; Karen Fauman; Elaine Cooley; Gail M Annich; Timothy T Cornell
Journal:  ASAIO J       Date:  2011 Sep-Oct       Impact factor: 2.872

2.  Bilateral Whole Lung Lavage in Hereditary Pulmonary Alveolar Proteinosis in a 4-year-old Child Using Extracorporeal Membrane Oxygenation.

Authors:  Prahlad Prabhudesai; Indu Khosla; Satish Kulkarni; Manish Kumar Arya; Abha Pandey; Namrata Yadav
Journal:  Indian J Crit Care Med       Date:  2021-09

3.  Whole lung lavage of nine children with pulmonary alveolar proteinosis: experience in a tertiary lung center.

Authors:  Radpay Badiozaman; Parsa Tahereh; Dabir Shideh; Boloursaz Mohammadreza; Arbab Ahmadreza; Tabatabaei Seyyedahmad
Journal:  Iran J Pediatr       Date:  2013-02       Impact factor: 0.364

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.